Confo Therapeutics enters into drug discovery collaboration with Lundbeck Ghent, Belgium – September 26, 2017 Confo Therapeutics, an emerging drug discovery company, today announced that it has entered into a drug discovery collaboration with H. Lundbeck A/S, a global pharmaceutical company specializing in psychiatric and neurological disorders. The goal of the collaboration is to deploy […]
Archive for the
‘Press Releases’ Category
Confo Therapeutics is awarded EUR 2.6M in non-dilutive funding for the discovery of new fibrosis treatments and for expanding the use of its unique Confo® technology Ghent, Belgium – February 1, 2017 Confo Therapeutics, an emerging drug discovery company, today announced that it has received a €1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). […]
Confo Therapeutics to appoint John Berriman as Chairman of the Board Brussels, December 15, 2016 [09:00 CET] – Confo Therapeutics, an emerging drug discovery company, today announced the appointment of John Edward Berriman as non-executive director and chairman of the board of directors, starting December 21. Commenting on the board appointment, Dr. Cedric Ververken, CEO, […]
Confo Therapeutics appoints Dr. Cedric Ververken as Chief Executive Officer Brussels, September 7, 2016 [09:00 CET] – Confo Therapeutics, an emerging drug discovery company, announces the appointment of Cedric Ververken as CEO and board member, starting October 1. Dr. Ververken will lead the transition of Confo Therapeutics from a technology company to a drug […]
Confo Therapeutics appoints Dr Christel Menet as Chief Scientific Officer Brussels, May 10, 2016 [09:00 CET] – Confo Therapeutics, an emerging drug discovery company, announced today that Dr Christel Menet is joining the company as Chief Scientific Officer, effective now. Dr. Menet will lead the research activities and build Confo Therapeutics’ pipeline of development programs […]
Confo Therapeutics secures €6.7 million in first financing round Investment will support first-in-class development programs for pathway selective drugs targeting GPCRs Brussels, Tuesday 02 February, 2016 [09:00 GMT] – Confo Therapeutics, an emerging drug discovery company, announced today the completion of its first financing round at €6.7 million. Incorporated in June 2015 by VIB and […]